Yantai Dongcheng Pharmaceutical Group Co.,Ltd. / Fundamentals
Income statement
- Net revenue
€341.10M - Cost of goods sold
€177.00M - Gross profit
€164.10M - SG&A expenses
€72.03M - R&D expenses
€36.47M - EBITDA
€31.42M - D&A
-€688.23K - EBIT
€27.37M - Interest expenses
€12.32M - EBT
€20.93M - Tax expenses
€9.90M - Net income
€19.35M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€59.61M - Changes in working capital
€0.00 - Operating cash flow
€69.06M - Capex
€44.52M - Other investing cash flow
€1.71M - Net investing cash flow
-€64.63M - Total cash dividends paid
-€18.71M - Issuance of common stock
€0.00 - Debt repayment
-€31.81M - Other financing cash flow
€28.28M - Net financing cash flow
-€22.25M - Foreign exchange effects
€1.43M - Net change in cash
-€16.48M - Cash at end of period
€85.62M - Free cash flow
€113.58M
Balance sheet
- Cash and cash equivalents
€89.46M - Cash and short-term investments
€113.63M - Total receivables
€119.54M - Inventory
€75.81M - Other current assets
€9.89M - Total current assets
€318.87M - Property, plant & equipment
€300.06M - Goodwill
€300.99M - Intangible assets
€65.78M - Long-term investments
€44.14M - Other non-current assets
€35.74M - Total non-current assets
€759.80M - Total assets
€1.08B - Accounts payable
€74.89M - Short-term debt
€37.74M - Other current liabilities
€70.05M - Total current liabilities
€193.57M - Long-term debt
€54.53M - Deferred tax liabilities
€2.03M - Other non-current liabilities
€147.68M - Total non-current liabilities
€228.01M - Total liabilities
€421.58M - Common stock
€99.32M - Retained earnings
€171.93M - Other equity
€35.38M - Total equity
€657.08M - Total liabilities and shareholders' equity
€1.08B
Company information
- Market capitalization
€1.44B - Employees
2.5K - Enterprise Value
€12.45B
Company ratios
- Gross margin
-
48.1% Better than peer group: 37.3% - EBITDA margin
-
9.2% Worse than peer group: 20.9% - EBIT margin
-
8.0% Worse than peer group: 17.2% - EBT margin
-
6.1% Worse than peer group: 17.7% - Net margin
-
5.7% Worse than peer group: 14.7% - ROE
-
2.9% Worse than peer group: 10.1% - ROA
-
1.8% Worse than peer group: 7.9% - Asset turnover
-
31.6% Much worse than peer group: 52.8% - FCF margin
-
7.2% Better than peer group: -2.5% - FCF yield
1.7% - Efficiency ratio
90.8% - Net sales per employee
-
€138.15K - Net income per employee
-
€7.84K